You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 35 Issue 3

February 2012

Volume 35, Issue 3

Pages 319–402

  1. RANDOMISED CLINICAL TRIALS

    1. Top of page
    2. RANDOMISED CLINICAL TRIALS
    3. INFLAMMATORY BOWEL DISEASE
    4. IRRITABLE BOWEL SYNDROME
    5. PAEDIATRIC OESOPHAGITIS
    6. VILLOUS ATROPHY
    7. INVITED COMMENTARIES
    8. LETTERS TO THE EDITORS
    1. You have free access to this content
      Randomised clinical trial: pregabalin attenuates the development of acid-induced oesophageal hypersensitivity in healthy volunteers – a placebo-controlled study (pages 319–326)

      Y. C. Chua, K. S. Ng, A. Sharma, J. Jafari, S. Surguy, E. Yazaki, C. H. Knowles and Q. Aziz

      Version of Record online: 27 DEC 2011 | DOI: 10.1111/j.1365-2036.2011.04955.x

    2. You have free access to this content
      Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis (pages 327–334)

      S. Oliva, G. Di Nardo, F. Ferrari, S. Mallardo, P. Rossi, G. Patrizi, S. Cucchiara and L. Stronati

      Version of Record online: 8 DEC 2011 | DOI: 10.1111/j.1365-2036.2011.04939.x

  2. INFLAMMATORY BOWEL DISEASE

    1. Top of page
    2. RANDOMISED CLINICAL TRIALS
    3. INFLAMMATORY BOWEL DISEASE
    4. IRRITABLE BOWEL SYNDROME
    5. PAEDIATRIC OESOPHAGITIS
    6. VILLOUS ATROPHY
    7. INVITED COMMENTARIES
    8. LETTERS TO THE EDITORS
    1. You have free access to this content
      Predictors of dose escalation of adalimumab in a prospective cohort of Crohn’s disease patients (pages 335–341)

      E. Bultman, C. de Haar, A. van Liere-Baron, H. Verhoog, R. L. West, E. J. Kuipers, Z. Zelinkova and C. Janneke van der Woude

      Version of Record online: 22 DEC 2011 | DOI: 10.1111/j.1365-2036.2011.04946.x

    2. You have free access to this content
      Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease (pages 342–349)

      A. V. Weizman, E. Ahn, R. Thanabalan, W. Leung, K. Croitoru, M. S. Silverberg, A. Hillary Steinhart and G. C. Nguyen

      Version of Record online: 18 DEC 2011 | DOI: 10.1111/j.1365-2036.2011.04956.x

  3. IRRITABLE BOWEL SYNDROME

    1. Top of page
    2. RANDOMISED CLINICAL TRIALS
    3. INFLAMMATORY BOWEL DISEASE
    4. IRRITABLE BOWEL SYNDROME
    5. PAEDIATRIC OESOPHAGITIS
    6. VILLOUS ATROPHY
    7. INVITED COMMENTARIES
    8. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
      Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study (pages 360–367)

      K. Tillisch, J. Labus, B. Nam, J. Bueller, S. Smith, B. Suyenobu, J. Siffert, J. McKelvy, B. Naliboff and E. Mayer

      Version of Record online: 3 JAN 2012 | DOI: 10.1111/j.1365-2036.2011.04958.x

  4. PAEDIATRIC OESOPHAGITIS

    1. Top of page
    2. RANDOMISED CLINICAL TRIALS
    3. INFLAMMATORY BOWEL DISEASE
    4. IRRITABLE BOWEL SYNDROME
    5. PAEDIATRIC OESOPHAGITIS
    6. VILLOUS ATROPHY
    7. INVITED COMMENTARIES
    8. LETTERS TO THE EDITORS
    1. You have free access to this content
      Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study (pages 368–379)

      E. Hassall, R. Shepherd, S. Koletzko, M. Radke, C. Henderson and P. Lundborg

      Version of Record online: 18 DEC 2011 | DOI: 10.1111/j.1365-2036.2011.04950.x

  5. VILLOUS ATROPHY

    1. Top of page
    2. RANDOMISED CLINICAL TRIALS
    3. INFLAMMATORY BOWEL DISEASE
    4. IRRITABLE BOWEL SYNDROME
    5. PAEDIATRIC OESOPHAGITIS
    6. VILLOUS ATROPHY
    7. INVITED COMMENTARIES
    8. LETTERS TO THE EDITORS
    1. You have free access to this content
      Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practice (pages 380–390)

      K. Pallav, D. A. Leffler, S. Tariq, T. Kabbani, J. Hansen, A. Peer, A. Bhansali, R. Najarian and C. P. Kelly

      Version of Record online: 6 DEC 2011 | DOI: 10.1111/j.1365-2036.2011.04938.x

  6. INVITED COMMENTARIES

    1. Top of page
    2. RANDOMISED CLINICAL TRIALS
    3. INFLAMMATORY BOWEL DISEASE
    4. IRRITABLE BOWEL SYNDROME
    5. PAEDIATRIC OESOPHAGITIS
    6. VILLOUS ATROPHY
    7. INVITED COMMENTARIES
    8. LETTERS TO THE EDITORS
    1. You have free access to this content
      Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease (pages 391–392)

      P. Henderson, D. C. Wilson and J. Satsangi

      Version of Record online: 3 JAN 2012 | DOI: 10.1111/j.1365-2036.2011.04921.x

    2. You have free access to this content
      Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease: authors’ reply (pages 392–393)

      C. Jakobsen, J. Bartek Jr, V. Wewer, I. Vind, P. Munkholm, R. Groen and A. Paerregaard

      Version of Record online: 3 JAN 2012 | DOI: 10.1111/j.1365-2036.2011.04960.x

    3. You have free access to this content
      Evolution of GERD over 5 years (pages 393–394)

      P. Aro and J. Ronkainen

      Version of Record online: 3 JAN 2012 | DOI: 10.1111/j.1365-2036.2011.04943.x

    4. You have free access to this content
      Evolution of GERD over 5 years: author’s reply (pages 395–396)

      P. Malfertheiner

      Version of Record online: 3 JAN 2012 | DOI: 10.1111/j.1365-2036.2011.04961.x

    5. You have free access to this content
      Mortality in patients hospitalised with Crohn’s disease (pages 396–397)

      J. Siffledeen, M. J. Goldacre and S. Travis

      Version of Record online: 3 JAN 2012 | DOI: 10.1111/j.1365-2036.2011.04942.x

    6. You have free access to this content
      Mortality in patients hospitalised with Crohn’s disease: authors’ reply (pages 397–398)

      N. Kennedy, J. Bauer, D. Clark, A. Crowe, A. Knight, J. Nicholls and J. Satsangi

      Version of Record online: 3 JAN 2012 | DOI: 10.1111/j.1365-2036.2011.04954.x

    7. You have free access to this content
      Prucalopride for chronic intestinal pseudo-obstruction (pages 398–399)

      P. Oustamanolakis and J. Tack

      Version of Record online: 3 JAN 2012 | DOI: 10.1111/j.1365-2036.2011.04947.x

  7. LETTERS TO THE EDITORS

    1. Top of page
    2. RANDOMISED CLINICAL TRIALS
    3. INFLAMMATORY BOWEL DISEASE
    4. IRRITABLE BOWEL SYNDROME
    5. PAEDIATRIC OESOPHAGITIS
    6. VILLOUS ATROPHY
    7. INVITED COMMENTARIES
    8. LETTERS TO THE EDITORS
    1. You have free access to this content
      Why thiopurine metabolites are relevant (pages 400–401)

      A. B. Friedman, M. P. Sparrow and P. R. Gibson

      Version of Record online: 3 JAN 2012 | DOI: 10.1111/j.1365-2036.2011.04940.x

    2. You have free access to this content
      Why thiopurine metabolites are relevant: authors’ reply (pages 401–402)

      Y. González-Lama and J. P. Gisbert

      Version of Record online: 3 JAN 2012 | DOI: 10.1111/j.1365-2036.2011.04957.x

SEARCH

SEARCH BY CITATION